ArticleGene reports2022
Wharton's jelly-mesenchymal stem cells treatment for severe COVID 19 patients: 1-year follow-up.
Mahshid Saleh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleGene reports2022
Mahshid Saleh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.